Akademik Veri Yönetim Sistemi
CHROMATOGRAPHIA, cilt.77, sa.3-4, ss.365-371, 2014 (SCI-Expanded)
A sensitive, selective and accurate ultra performance liquid chromatographic method has been developed and validated for the simultaneous determination of bisoprolol fumarate and hydrochlorothiazide in their combined dosage forms and as well as in spiked human urine samples. The separation was achieved on an Acquity UPLC BEH C18 1.7 mu m (2.1 x 50 mm) column, at 40 degrees C with mobile phase consisting of acetonitrile: phosphate buffer (20 mM) at pH 3.0 with a gradient elution at 225 nm. Bisoprolol fumarate and hydrochlorothiazide were well separated in <1.5 min with good resolution and without any tailing and interference of excipients. The method was fully validated according to ICH guidelines in terms of accuracy, precision, linearity and specificity. A linear response was observed over the concentration range 0.5-150 mu g mL(-1) for hydrochlorothiazide and 0.5-250 mu g mL(-1) for bisoprolol fumarate. Limit of detection and limit of quantitation for hydrochlorothiazide were calculated as 0.01 and 0.03 mu g mL(-1), respectively, and for bisoprolol fumarate were 0.07 and 0.21 mu g mL(-1), respectively. Moreover, bisoprolol fumarate and hydrochlorothiazide were subjected to degradation conditions such as hydrolytic, oxidative and thermal stress conditions to evaluate the ability of the proposed method for the separation of bisoprolol fumarate and hydrochlorothiazide from their degradation compounds.